TWO SIGMA INVESTMENTS, LP - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 249 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.5%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$7,750,000
-35.1%
113,472
-68.7%
0.03%
-3.7%
Q3 2021$11,938,000
-60.2%
362,204
-23.8%
0.03%
-60.3%
Q2 2021$30,022,000
+81.9%
475,038
+23.5%
0.07%
+58.1%
Q1 2021$16,509,000
+41.0%
384,731
+87.9%
0.04%
+26.5%
Q4 2020$11,711,000
+24.8%
204,740
-34.2%
0.03%
+3.0%
Q3 2020$9,382,000
-47.7%
310,980
-43.4%
0.03%
-62.9%
Q2 2020$17,948,000
+55.3%
549,538
+27.4%
0.09%
-5.3%
Q1 2020$11,556,000
+74.1%
431,339
+99.0%
0.09%
+370.0%
Q4 2019$6,638,000
+89.6%
216,777
+49.2%
0.02%
+66.7%
Q3 2019$3,501,000145,3130.01%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,114,962$63,776,00024.13%
Octagon Capital Advisors LP 548,374$31,367,00010.87%
Ghost Tree Capital, LLC 325,000$18,590,0004.14%
Burrage Capital Management LLC 81,357$4,654,0003.55%
Aufman Associates Inc 53,642$3,068,0002.75%
ACUTA CAPITAL PARTNERS, LLC 167,054$9,555,0002.60%
Cormorant Asset Management, LP 1,866,108$106,741,0002.54%
Tri Locum Partners LP 121,409$6,945,0002.52%
venBio Partners LLC 490,471$28,055,0002.48%
HHLR ADVISORS, LTD. 5,028,289$287,618,0002.29%
View complete list of APELLIS PHARMACEUTICALS INC shareholders